[1] NATHAN D M，BUSE J B，DAVIDSON M B，et al. Management of hyperglycemia in type 2 Diabetes： a consensus algorithm for the initiation and adjustment of therapy[J] .Diabetes Care，2006，29(8)：1963-1972. [2] FONSECA V，ROSENSTOCK J，PATWARDHAN R，et al. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus[J] .JAMA，2000，283：1695-1702. [3] WOLFFENBUTTEL B H R，GOMIS R，SQUATRITO S，et al. Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in type 2 diabetes patients[J] .Diabet Med，2000，17：40-47. [4] RASKIN P，DOLE J F，RAPPAPORT E B. Rosiglitazone improves glycemic control in poorly controlled，insulin-treated type 2 diabetes (T2D) [J] .Diabetes，1999，48(suppl 1)：94. [5] THE TASK FORCE FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION OF THE EUROPEAN SOCIETY OF HYPERTENSION（ESH） AND OF THE EUROPEAN SOCIETY OF CARDIOLOGY(ESC).2007 Guidelines for the management of arterial hypertension[J] .Eur Heart J，2007，28：1462-1536. [6] STEWART M，JONES N P，KREIDER M，et al. Combination effects of rosiglitazone and atorvastatin on the dyslipidemia associated with type 2 diabetes[J] .Diabetologia，2001，44(Supple 1)：854. [7] NISSEN S E，WOLSKI K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes[J] . N Engl J Med，2007，356(24)：2457-2471.